
(AGENPARL) – BRUXELLES ven 28 aprile 2023 REGULATORY SCRUTINY BOARD OPINIONS Revision of the general pharmaceutical legislation Revision of the EU legislation on medicines for children and rare diseases
Fonte/Source: https://data.consilium.europa.eu/doc/document/ST-8759-2023-ADD-2/en/pdf